EGFR and lung cancer: Traditional treatment for lung cancer has been surgery and radiochemotherapy, but targeted therapies are increasingly adopted for patients who have the druggable aberrations such as epidermal growth factor receptor (EGFR) mutations or gene fusions involving ALK, ROS1, and NTRK genes [2-5].